Author + information
- Received November 10, 2010
- Revision received May 27, 2011
- Accepted June 29, 2011
- Published online October 1, 2011.
- Andrew C.Y. To, MBChB,
- Ashwat Dhillon, MD and
- Milind Y. Desai, MD⁎ ()
- ↵⁎Reprint requests and correspondence:
Dr. Milind Y. Desai, Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, J1-5, 9500 Euclid Avenue, Cleveland, Ohio 44195
Hypertrophic cardiomyopathy is a complex genetic cardiovascular disorder with substantial variability in phenotypic expression and natural progression. Recent research demonstrates the incremental utility of cardiac magnetic resonance in the diagnosis, therapeutic planning, and prognostication of this disease. The increasing incorporation of multimodality imaging of hypertrophic cardiomyopathy in clinical practice will continue to improve our understanding of the subtle morphologic differences and their prognostic implications.
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received November 10, 2010.
- Revision received May 27, 2011.
- Accepted June 29, 2011.
- American College of Cardiology Foundation